Anna Nilsson new vice-director on Cancer Research KI's board
Anna Nilsson, Professor of Paediatric Oncology at Karolinska Institutet (KI) and Senior Consultant at Astrid Lindgren Children’s Hospital, has been appointed Vice Director of the Board of Cancer Research KI (CRKI). The organisation brings together cancer research from more than 400 research groups across the university and works to ensure that new knowledge benefits patients.
Cancer Research KI is an umbrella organisation for cancer research at Karolinska Institutet. It brings together researchers from multiple departments and campuses with the aim of contributing to new scientific discoveries and enabling research findings to be translated more rapidly into healthcare practice.
CRKI now welcomes a new Vice Director as Anna Nilsson takes up her position on the Board. She is a professor and senior consultant at the Department of Women’s and Children’s Health, where her research includes infections and immunity in children with cancer.
“It is exciting and somewhat challenging, given the breadth and success of cancer research at KI. It is also rewarding to represent paediatric cancer research conducted across several KI departments in this context,” says Anna Nilsson.
In her role as Vice Director, she aims to strengthen the child perspective within cancer research and to create favourable conditions for researchers who combine academic work with clinical practice. CRKI is part of the Karolinska Comprehensive Cancer Center and collaborates both nationally and internationally. According to Anna Nilsson, collaboration is central to strengthening research and improving patient care.
“I want to help improve the conditions for researchers who also work in healthcare so that research at KI can lead more rapidly to patient benefit. If we are a strong collaborative partner, this will benefit both our researchers and our patients,” she says.
Her term as Vice Director runs from 2026 to 2028.